From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,593,128 shares, representing 2.11% for $0.89 million under the buyback announced on June 15, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.55 USD | -3.53% | -18.30% | -73.04% |
May. 14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (TOI) TOI MANAGEMENT LLC Reports Q1 Revenue $94.7M, vs. Street Est of $95.2M | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-73.04% | 40.94M | |
+17.74% | 82.59B | |
-29.66% | 69.86B | |
0.00% | 26.5B | |
+3.06% | 17.29B | |
-12.16% | 16.61B | |
+2.47% | 15.56B | |
+74.82% | 13.2B | |
+0.76% | 12.75B | |
+73.52% | 12.6B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on June 15, 2023.